Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -48.56% is in line with its 5-year average of -51.17%, around the middle of its 5-year range (-154.15%–5.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 56.57% above its 12-month average of -111.80%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -48.56%.
RETURN ON EQUITY (ROE)
-48.56%
RETURN ON EQUITY (ROE) AVG TTM
-111.80%
RETURN ON EQUITY (ROE) AVG 3Y
-83.79%
RETURN ON EQUITY (ROE) AVG 5Y
-51.17%
RETURN ON EQUITY (ROE) AVG 10Y
-50.14%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+56.57%
CURRENT VS 3Y AVG
+42.05%
CURRENT VS 5Y AVG
+5.11%
CURRENT VS 10Y AVG
+3.15%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-15.59%
vs the sector median at left
Tandem Diabetes Care, Inc.
Market Cap
$1.11B
Return on Equity (ROE)
-48.56%
TTM Avg
-111.80%
3Y Avg
-83.79%
5Y Avg
-51.17%
Market Cap
$1.10B
Return on Equity (ROE)
1.05%
TTM Avg
-23.37%
3Y Avg
-7.64%
5Y Avg
-0.10%
Market Cap
$1.11B
Return on Equity (ROE)
-281.14%
TTM Avg
-124.20%
3Y Avg
-84.35%
5Y Avg
-63.72%
Market Cap
$1.10B
Return on Equity (ROE)
-57.77%
TTM Avg
-49.78%
3Y Avg
-41.82%
5Y Avg
-41.82%
Market Cap
$1.09B
Return on Equity (ROE)
-6.16%
TTM Avg
-10.85%
3Y Avg
-14.08%
5Y Avg
-9.38%
Market Cap
$1.09B
Return on Equity (ROE)
-39.54%
TTM Avg
-24.09%
3Y Avg
36.77%
5Y Avg
36.77%
Market Cap
$1.13B
Return on Equity (ROE)
N/A
TTM Avg
35.70%
3Y Avg
35.70%
5Y Avg
35.70%
Market Cap
$1.08B
Return on Equity (ROE)
22.66%
TTM Avg
22.95%
3Y Avg
21.85%
5Y Avg
17.09%
Market Cap
$1.13B
Return on Equity (ROE)
-244.91%
TTM Avg
-17.45%
3Y Avg
-30.16%
5Y Avg
-48.76%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tandem Diabetes Care, Inc. (TNDM) | $1.11B | -48.56% | -111.80% | -83.79% | -51.17% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 1.05% | -23.37% | -7.64% | -0.10% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | -281.14% | -124.20% | -84.35% | -63.72% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | -57.77% | -49.78% | -41.82% | -41.82% |
| OPKO Health, Inc. (OPK)vs › | $1.09B | -6.16% | -10.85% | -14.08% | -9.38% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -39.54% | -24.09% | 36.77% | 36.77% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | 35.70% | 35.70% | 35.70% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 22.66% | 22.95% | 21.85% | 17.09% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | -244.91% | -17.45% | -30.16% | -48.76% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 2.51% | 3.60% | 0.50% | -7.05% |
ROE
-48.6%
ROA
-5.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -48.56% |
| 2026-03-31 | -71.41% |
| 2025-12-31 | -131.93% |
| 2025-09-30 | -152.95% |
| 2025-06-30 | -154.15% |
| 2025-03-31 | -118.40% |
| 2024-12-31 | -36.50% |
| 2024-09-30 | -53.33% |
| 2024-06-30 | -58.36% |
| 2024-03-31 | -58.20% |
| 2023-12-31 | -70.98% |
| 2023-09-30 | -66.39% |
| 2023-06-30 | -68.18% |
| 2023-03-31 | -60.15% |
| 2022-12-31 | -21.50% |
| 2022-09-30 | -16.10% |
| 2022-06-30 | -2.93% |
| 2022-03-31 | 1.35% |
| 2021-12-31 | 3.59% |
| 2021-09-30 | 5.58% |
| 2021-06-30 | 1.89% |
| 2021-03-31 | -7.84% |
| 2020-12-31 | -9.39% |
| 2020-09-30 | -14.92% |
| 2020-06-30 | -15.77% |
| 2020-03-31 | -8.03% |
| 2019-12-31 | -12.70% |
| 2019-09-30 | -14.20% |
| 2019-06-30 | -37.88% |
| 2019-03-31 | -93.34% |
| 2018-12-31 | -93.40% |
| 2018-09-30 | -119.30% |
| 2018-06-30 | -459.50% |
| 2018-03-31 | -691.53% |
| 2016-06-30 | -219.77% |
| 2016-03-31 | -156.05% |
| 2015-12-31 | -114.10% |
| 2015-09-30 | -110.61% |
| 2015-06-30 | -90.15% |
| 2015-03-31 | -77.04% |
| 2014-12-31 | -145.72% |
| 2014-09-30 | -125.47% |
| 2014-06-30 | -93.16% |
| 2014-03-31 | -76.02% |
| 2013-12-31 | -54.65% |
